Skip to Main Content

Paper Details

The functional impact of rare variation across the regulatory cascade.
Cell Genom
1
2023
Alzheimer's disease, Atherosclerosis, frameshift variants, human, human genome, rare genetic variants, rare variants, schizophrenia, stop variants, transcriptomes
Author NameAffiliation
Taibo LiJohns Hopkins University School of Medicine
Nicole M FerraroStanford University
Benjamin J StroberJohns Hopkins University School of Medicine
Benjamin J StroberHarvard School of Public Health
François AguetBroad Institute of MIT and Harvard
Silva Kasela
Silva KaselaColumbia University
Marios ArvanitisJohns Hopkins University School of Medicine
Marios ArvanitisJohns Hopkins School of Medicine
Bohan NiJohns Hopkins University
Laurens WielStanford University School of Medicine
Elliot HershbergStanford University
Kristin G ArdlieBroad Institute of MIT and Harvard
Dan E ArkingMcKusick-Nathans Institute, Johns Hopkins University School of Medicine
Rebecca L Beerand Blood Institute, National Institutes of Health
Jennifer A BrodyCardiovascular Health Research Unit, University of Washington
Thomas W BlackwellSchool of Public Health, University of Michigan ann arbor
Clary B ClishBroad Institute of MIT and Harvard
Clary B ClishBroad Institute of MIT and Harvard
Stacey GabrielBroad Institute of MIT and Harvard
Stacey GabrielBroad Institute of MIT and Harvard
Robert E GersztenBroad Institute of MIT and Harvard
Robert E GersztenCardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School
Xiuqing GuoThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Namrata GuptaBroad Institute of MIT and Harvard
W Craig JohnsonUniversity of Washington
Tuuli Lappalainen
Tuuli LappalainenColumbia University
Tuuli Lappalainen
Tuuli LappalainenColumbia University
Henry J LinThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Yongmei LiuDuke University School of Medicine
Deborah A NickersonUniversity of Washington
Deborah A NickersonUniversity of Washington
George J Papanicolaouand Blood Institute, National Institutes of Health
Jonathan K PritchardStanford University
Pankaj Qasbaand Blood Institute, National Institutes of Health
Ali ShojaieUniversity of Washington School of Public Health
Josh SmithUniversity of Washington
Nona SotoodehniaCardiovascular Health Research Unit, University of Washington
Nona SotoodehniaCardiovascular Health Research Unit, University of Washington
Kent D TaylorThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Russell P TracyLaboratory for Clinical Biochemistry Research, University of Vermont
David Van Den BergUniversity of Southern California
Matthew T WheelerStanford University School of Medicine
Matthew T WheelerStanford University School of Medicine
Stephen S RichCenter for Public Health Genomics, University of Virginia
Stephen S RichThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Alexis BattleJohns Hopkins University School of Medicine
Alexis BattleMalone Center for Engineering of Healthcare, Johns Hopkins University
  • 1 - 50

Datasets